Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

103.800
-3.700-3.44%
Volume:17.01M
Turnover:1.76B
Market Cap:181.03B
PE:189.37
High:106.400
Open:104.300
Low:101.500
Close:107.500
52wk High:112.700
52wk Low:69.550
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:0.95
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.548
ROE:7.01%
ROA:2.10%
PB:7.48
PE(LYR):189.37
PS:9.88

Loading ...

Sihuan Pharmaceutical H1 Profit Jumps on Medical Aesthetics Unit Strength

Reuters
·
Aug 26

Mainland Benchmarks Edge Higher in Morning Trade; Nonferrous Metals and Brokerages Lead While Optical Modules Retreat; Hang Seng and Tech Index Climb Over 1% on Biotech Surge

Deep News
·
Aug 26

Movement Alert|INNOVENT BIO Rises 8.89% in Regular Trading, H1 Net Profit Surges 50% with 2030 Revenue Target of RMB 35-40 Billion

Market Focus
·
Aug 26

INNOVENT BIO Surges 6% on Robust H1 Earnings, Sets Ambitious 2030 Revenue Target

Stock News
·
Aug 26

JPMorgan Raises Stake in Innovent Bio With HK$241M Share Purchase

Deep News
·
Aug 26

China's Clover Biopharma H1 Revenue Drops Sharply, Flags Going-Concern Doubt

Reuters
·
Aug 26

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

Reuters
·
Aug 25

Innovent Biologics' H1 Profit Jumps 50%

MT Newswires Live
·
Aug 25

Innovent Biologics - Re-Designates Ronald Hao Xi Ede as Non-Executive Director Effective September 1, 2026

THOMSON REUTERS
·
Aug 25

Innovent Announces 2026 Interim Results and Business Updates

THOMSON REUTERS
·
Aug 25

INNOVENT BIO Reports First-Half Profit of RMB 1.253 Billion, Up 50.2% Year-on-Year

Stock News
·
Aug 25

Innovent Biologics Delivers 1H26 Net Profit of RMB 1.25 Billion on 45% Revenue Surge, Accelerates Global Pipeline

Bulletin Express
·
Aug 25

Innovent Biologics - Potential to Maintain Rapid Revenue Growth to RMB35 Bln to RMB40 Bln Total Revenue by 2030

THOMSON REUTERS
·
Aug 25

Innovent Biologics H1 FY26 IFRS Profit Climbs 50.2% to RMB 1.25 Billion; Revenue Rises 44.8% to RMB 8.62 Billion

Reuters
·
Aug 25

Innovent Biologics H1 Revenue RMB 8,617.8 Million

THOMSON REUTERS
·
Aug 25

Movement Alert|INNOVENT BIO Falls 3.13% in Regular Trading, Biotech Sector Under Pressure Ahead of Interim Results

Market Focus
·
Aug 24

Movement Alert|INNOVENT BIO Rises 4.43% in Regular Trading, Morgan Stanley Raises Target Price to HK$138.5 Amid Strong H1 Revenue Expectations

Market Focus
·
Aug 20

Movement Alert|INNOVENT BIO Rises 3.47% in Regular Trading, BlackRock Stake Increase and Strong H1 Revenue Fuel Optimism

Market Focus
·
Aug 19

Innovent Biologics (SEHK:1801), Why Is It Back In The Spotlight?

Simply Wall St.
·
Aug 19

BlackRock Expands Stake in INNOVENT BIO with Recent Share Purchase

Stock News
·
Aug 17